Yakira Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-172,471
Closed -$1.04M 180
2019
Q4
$1.04M Buy
+172,471
New +$998K 0.3% 76

Yakira Capital Management's ACHN Position: Q1 2020 in Review

Yakira Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 172,471 shares — an estimated $1.04M sold.

Yakira Capital Management first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $1.04M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Yakira Capital Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Yakira Capital Management sold 172,471 Achillion Pharmaceuticals shares in Q1 2020, an estimated $1.04M.
  • Yakira Capital Management first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Yakira Capital Management's Achillion Pharmaceuticals position peaked at $1.04M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Yakira Capital Management's 13F filing for Q1 2020, filed 14 May 2020.